1. Home
  2. NEXM vs RPID Comparison

NEXM vs RPID Comparison

Compare NEXM & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexMetals Mining Corp.

NEXM

NexMetals Mining Corp.

HOLD

Current Price

$2.33

Market Cap

82.7M

Sector

N/A

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.31

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXM
RPID
Founded
N/A
2006
Country
Canada
United States
Employees
204
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
84.8M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
NEXM
RPID
Price
$2.33
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
35.5K
237.0K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1044.00
2.78
EPS
0.63
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
$3.67
N/A
Revenue Growth
N/A
19.74
52 Week Low
$2.03
$1.34
52 Week High
$6.65
$4.94

Technical Indicators

Market Signals
Indicator
NEXM
RPID
Relative Strength Index (RSI) 48.19 24.12
Support Level $2.29 N/A
Resistance Level $2.38 $2.18
Average True Range (ATR) 0.17 0.11
MACD -0.01 -0.02
Stochastic Oscillator 28.33 5.00

Price Performance

Historical Comparison
NEXM
RPID

About NEXM NexMetals Mining Corp.

NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: